• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同疾病状态结核病患者肠道微生物组的改变。

Alterations in the Gut Microbiome of Individuals With Tuberculosis of Different Disease States.

机构信息

Department of Epidemiology and Biostatistics, College of Public Health, Xinjiang Medical University, Urumqi, China.

Department of Women and Children and Community Health, Xinjiang Production and Construction Corps Center for Disease Control and Prevention, Urumqi, China.

出版信息

Front Cell Infect Microbiol. 2022 Mar 29;12:836987. doi: 10.3389/fcimb.2022.836987. eCollection 2022.

DOI:10.3389/fcimb.2022.836987
PMID:35425720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9001989/
Abstract

OBJECTIVE

There is evidence that the gut microbiota play a regulatory role in the occurrence and progression of tuberculosis. The purpose of the current study was to explore the alterations in gut microbiome under different tuberculosis disease stages in the Uyghur population, clarify the composition of microbial taxonomy, search for microbial biomarkers and provide innovative ideas for individual immune prevention and for control strategies.

DESIGN

A case-control study of Uyghur individuals was performed using 56 cases of pulmonary tuberculosis (PTB), 36 cases of latent tuberculosis infection (LTBI) and 50 healthy controls (HC), from which stool samples were collected for 16S rRNA gene sequencing.

RESULTS

The results showed that the alpha diversity indexes of the PTB group were lower than those of the other two groups (P <0.001), while only observed species were different between LTBI and HC (P <0.05). Beta diversity showed differences among the three groups (P = 0.001). At the genus level, the relative abundance of and increased, while and decreased in the PTB group, when compared with the other two groups, but the changes between the LTBI and HC groups were not significant. The classifier in the test set showed that the ability of the combined genus to distinguish between each two groups was 81.73, 87.26, and 86.88%, respectively, and the validation efficiency was higher than that of a single screened genus.

CONCLUSION

The gut microbiota of PTB patients was significantly disordered compared with LTBI and HC, while the changes of LTBI and HC were not significant. In the future, gut microbiota could be used as a non-invasive biomarker to assess disease activity.

摘要

目的

有证据表明,肠道微生物群在结核病的发生和发展中起调节作用。本研究旨在探讨维吾尔族人群在不同结核病阶段肠道微生物组的变化,阐明微生物分类组成,寻找微生物生物标志物,并为个体免疫预防和控制策略提供创新思路。

设计

采用病例对照研究,纳入 56 例肺结核(PTB)、36 例潜伏性结核感染(LTBI)和 50 例健康对照(HC)的维吾尔族个体,采集粪便样本进行 16S rRNA 基因测序。

结果

结果显示,PTB 组的 alpha 多样性指数低于其他两组(P<0.001),而 LTBI 和 HC 组之间仅观察到物种不同(P<0.05)。β多样性显示三组之间存在差异(P=0.001)。在属水平上,与其他两组相比,PTB 组的 和 相对丰度增加, 和 减少,但 LTBI 和 HC 组之间的变化不显著。在测试集中,分类器显示联合属区分每组的能力分别为 81.73%、87.26%和 86.88%,验证效率高于单一筛选属。

结论

与 LTBI 和 HC 相比,PTB 患者的肠道微生物群明显失调,而 LTBI 和 HC 的变化不明显。未来,肠道微生物群可以作为一种非侵入性生物标志物来评估疾病活动度。

相似文献

1
Alterations in the Gut Microbiome of Individuals With Tuberculosis of Different Disease States.不同疾病状态结核病患者肠道微生物组的改变。
Front Cell Infect Microbiol. 2022 Mar 29;12:836987. doi: 10.3389/fcimb.2022.836987. eCollection 2022.
2
The correlation between dysfunctional intestinal flora and pathology feature of patients with pulmonary tuberculosis.肠道菌群失调与肺结核患者病理特征的相关性。
Front Cell Infect Microbiol. 2022 Dec 21;12:1090889. doi: 10.3389/fcimb.2022.1090889. eCollection 2022.
3
[Correlation study between changes in intestinal microflora structure and immune indexes in newly treated patients with pulmonary tuberculosis].初治肺结核患者肠道菌群结构变化与免疫指标的相关性研究
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Dec 6;55(12):1486-1490. doi: 10.3760/cma.j.cn112150-20210728-00721.
4
Gut microbiota composition can reflect immune responses of latent tuberculosis infection in patients with poorly controlled diabetes.肠道微生物组成可以反映未控制良好的糖尿病患者潜伏性结核感染的免疫反应。
Respir Res. 2023 Jan 11;24(1):11. doi: 10.1186/s12931-023-02312-w.
5
Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans.结核分枝杆菌感染后全身炎症与 HIV 未感染者的肠道微生物组有关。
Eur J Clin Invest. 2019 May;49(5):e13068. doi: 10.1111/eci.13068. Epub 2019 Mar 15.
6
[A comparative study on the difference of gut microbiota and its biomarkers between patients with pulmonary tuberculosis and healthy controls].肺结核患者与健康对照者肠道微生物群及其生物标志物差异的比较研究
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Nov 12;44(11):939-946. doi: 10.3760/cma.j.cn112147-20210315-00170.
7
Features of gut microbiota in patients with anorexia nervosa.厌食症患者的肠道微生物群特征。
Chin Med J (Engl). 2022 Aug 20;135(16):1993-2002. doi: 10.1097/CM9.0000000000002362.
8
Alterations in the nasopharyngeal microbiota associated with active and latent tuberculosis.鼻咽微生物组的改变与活动性和潜伏性结核有关。
Tuberculosis (Edinb). 2022 Sep;136:102231. doi: 10.1016/j.tube.2022.102231. Epub 2022 Jul 21.
9
The potential mechanism of the progression from latent to active tuberculosis based on the intestinal microbiota alterations.基于肠道微生物群改变的潜伏性向活动性肺结核进展的潜在机制。
Tuberculosis (Edinb). 2023 Dec;143:102413. doi: 10.1016/j.tube.2023.102413. Epub 2023 Oct 8.
10
A metagenomic study of the gut microbiome in PTB'S disease.肺结核患者肠道微生物群的宏基因组学研究。
Microbes Infect. 2022 Mar;24(2):104893. doi: 10.1016/j.micinf.2021.104893. Epub 2021 Oct 25.

引用本文的文献

1
Gut microbiota and tuberculosis.肠道微生物群与结核病
Imeta. 2025 Jun 22;4(4):e70054. doi: 10.1002/imt2.70054. eCollection 2025 Aug.
2
The gut dysbiosis and plasma lipid metabolisms signatures in children with active tuberculosis.活动性肺结核患儿的肠道菌群失调与血浆脂质代谢特征
BMC Microbiol. 2025 Jul 8;25(1):425. doi: 10.1186/s12866-025-04141-x.
3
Sputum microbiota profiles of patients with rifampicin-resistant tuberculosis during the intensive-phase treatment.耐利福平肺结核患者强化期治疗期间的痰液微生物群概况

本文引用的文献

1
Analysis of IL-4 promoter and VNTR polymorphisms in Thai patients with pulmonary tuberculosis.泰国肺结核患者白细胞介素 4 启动子和 VNTR 多态性分析。
Trop Biomed. 2019 Dec 1;36(4):874-882.
2
Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting.肠道微生物群落失调与地方性活跃结核病患者血液生物标志物的相关性。
PLoS One. 2021 Jan 22;16(1):e0245534. doi: 10.1371/journal.pone.0245534. eCollection 2021.
3
Latent TB (LTBI) treatment: Challenges in India with an eye on 2025: "To Treat LTBI or not to treat, that is the question".
BMC Microbiol. 2025 Jul 1;25(1):373. doi: 10.1186/s12866-025-04091-4.
4
Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects.维多珠单抗治疗期间潜伏性结核感染的溃疡性结肠炎患者肠道微生物群多样性降低:对预防性抗结核作用的见解
BMC Microbiol. 2024 Dec 27;24(1):543. doi: 10.1186/s12866-024-03705-7.
5
Bad company? The pericardium microbiome in people investigated for tuberculous pericarditis in an HIV-prevalent setting.不良伙伴?在艾滋病流行地区对疑似结核性心包炎患者的心包微生物群进行的研究
Microbes Infect. 2025 Mar-Apr;27(3):105434. doi: 10.1016/j.micinf.2024.105434. Epub 2024 Nov 9.
6
Gut microbiota: a crucial player in the combat against tuberculosis.肠道微生物群:抗击结核病的关键因素。
Front Immunol. 2024 Oct 22;15:1442095. doi: 10.3389/fimmu.2024.1442095. eCollection 2024.
7
Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses.与潜伏性结核感染相关的嘌呤和嘧啶代谢改变:来自肠道微生物组和代谢组学分析的见解。
mSystems. 2024 Nov 19;9(11):e0081224. doi: 10.1128/msystems.00812-24. Epub 2024 Oct 22.
8
Non-sputum-based samples and biomarkers for detection of Mycobacterium tuberculosis: the hope to improve childhood and HIV-associated tuberculosis diagnosis.基于非痰液样本和生物标志物检测结核分枝杆菌:改善儿童和 HIV 相关结核病诊断的希望。
Eur J Med Res. 2024 Oct 18;29(1):502. doi: 10.1186/s40001-024-02092-z.
9
A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases.从固有微生物群角度看肺肠轴及其对呼吸系统疾病免疫反应的影响
Arch Microbiol. 2024 Feb 18;206(3):107. doi: 10.1007/s00203-024-03843-6.
10
Host microbiome in tuberculosis: disease, treatment, and immunity perspectives.结核病中的宿主微生物群:疾病、治疗及免疫视角
Front Microbiol. 2023 Sep 22;14:1236348. doi: 10.3389/fmicb.2023.1236348. eCollection 2023.
潜伏性结核(LTBI)治疗:印度面临的挑战及对 2025 年的展望:“治疗 LTBI 还是不治疗,这是个问题”。
Indian J Tuberc. 2020 Dec;67(4S):S43-S47. doi: 10.1016/j.ijtb.2020.09.028. Epub 2020 Oct 1.
4
Mycobacterium tuberculosis progresses through two phases of latent infection in humans.结核分枝杆菌在人体中经历潜伏感染的两个阶段。
Nat Commun. 2020 Sep 25;11(1):4870. doi: 10.1038/s41467-020-18699-9.
5
Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients.酒精性肝炎患者粪便细菌微生物群与疾病严重程度变化的相关性。
Gut Microbes. 2020 Nov 9;12(1):1785251. doi: 10.1080/19490976.2020.1785251. Epub 2020 Jul 20.
6
Mycobacterium tuberculosis, antimicrobials, immunity, and lung-gut microbiota crosstalk: current updates and emerging advances.结核分枝杆菌、抗生素、免疫和肺肠微生物群相互作用:最新进展和新兴进展。
Ann N Y Acad Sci. 2020 May;1467(1):21-47. doi: 10.1111/nyas.14300. Epub 2020 Jan 28.
7
IL-10 Impairs Local Immune Response in Lung Granulomas and Lymph Nodes during Early Infection.IL-10 抑制早期感染时肺部肉芽肿和淋巴结中的局部免疫反应。
J Immunol. 2020 Feb 1;204(3):644-659. doi: 10.4049/jimmunol.1901211. Epub 2019 Dec 20.
8
The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?肠道微生物组与结核病易感性和治疗反应:有罪还是无罪?
Cell Mol Life Sci. 2020 Apr;77(8):1497-1509. doi: 10.1007/s00018-019-03370-4. Epub 2019 Nov 15.
9
T cell-mediated regulation of the microbiota protects against obesity.T 细胞介导的微生物群调节可预防肥胖。
Science. 2019 Jul 26;365(6451). doi: 10.1126/science.aat9351.
10
Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against .肠道微生物群调节 Mincle 介导的肺树突状细胞激活以预防
Front Immunol. 2019 May 28;10:1142. doi: 10.3389/fimmu.2019.01142. eCollection 2019.